Delivery Order SPE2DB22D1106-SPE2DB24FFAZ4
Award Date
7/9/24
Potential Completion Date
7/30/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,534.96 firm fixed-price delivery order is for the supply of NPLATE 125 MCG vials, a specialty medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,225.49, is a delivery order for the supply of 4564881091 NPLATE 125 MCG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of July 3, 2024. This contract award is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NPLATE 125 MCG VIALS, a medical product, with a total ceiling value of $3,031.04 and a period of performance through April 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not designated as a set-aside contract. AmerisourceBergen holds a...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NPLATE 125 MCG VIALS, a pharmaceutical product, with a ceiling value of $2,225.49 and a period of performance through July 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of NPLATE 125 MCG VIALS. The contract is a Firm Fixed Price Delivery Order valued at $2,225.49 with a completion date of July 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that runs through November 2026. This IDC serves as a primary vehicle...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,450.98 firm fixed-price delivery order is for the supply of NPLATE 125 MCG VIALS, a specialty pharmaceutical product. This award is associated with a broader Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of NPLATE 125 MCG vials. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and a ceiling value of $4,450.98. The ultimate completion date for this contract is August 26, 2024. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this contract. The contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,031.04, is for the delivery of 4,568,104,138 vials of the drug Nplate (romiplostim) 125 mcg. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,302.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NPLATE 125 MCG vials, a specialty medication, to support military healthcare programs. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award, valued at $2,225.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NPLATE 125 MCG VIALS, a critical medical product, with a completion date of June 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...